Advertisement

Pegylated silica nanoparticles: cytotoxicity and macrophage uptake

  • Giulia Glorani
  • Riccardo Marin
  • Patrizia Canton
  • Marcella Pinto
  • Giamaica Conti
  • Giulio Fracasso
  • Pietro Riello
Research Paper

Abstract

Here, we present a thorough study of pegylated silica nanoparticle (SNP) interaction with different biological environments. The SNPs have a mean diameter of about 40 nm and are coated with polyethylene glycol (PEG) of different molecular weights. The physicochemical characterization of SNPs allowed the confirmation of the binding of PEG chains to the silica surface, the reproducibility of the synthesis and the narrow size-dispersion. In view of clarifying the SNP interaction with biological environments, we first assessed the SNP reactivity after the incubation with two cell lines (macrophages RAW 264.7 and primary human fibroblasts), observing a reduced toxicity of pegylated SNPs compared to the bare ones. Then, we investigated the effect of the protein adsorption on the SNP surface using the model serum protein, bovine serum albumin (BSA). We found that the protein adsorption takes place more heavily on poorly pegylated SNPs, promoting the uptake of the latter by macrophages and leading to an increased mortality of these cells. To better understand this mechanism by means of flow cytometry, the dye Ru(bpy)3Cl2 was incorporated in the SNPs. The overall results highlight the SNP potentialities as a drug delivery system, thanks to the low interactions with the macrophages.

Keywords

Silica Silica nanoparticles Polyethylene glycol PEG Pegylation Macrophage Interaction BSA Cell uptake Biocompatibility 

Notes

Acknowledgements

The authors thank Mr. A. Skripka for the helpful discussions.

Compliance with ethical standards

This study was funded by Fondazione Cariverona, Verona Nanomedicine Initiative and Italian Minister of Health RF-2010-2305526.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

11051_2017_3964_MOESM1_ESM.docx (4.7 mb)
ESM 1 Electronic Supplementary Information (ESI) available: [Details of the experimental procedure for the synthesis of mPEG5000-silane and mPEG550-silane, bare and pegylated SNPs and FSNPs; cell cultures; XRPD pattern and high magnification SEM image of bare SNPs (S), SEM micrographs of samples S25a, S8b, and S50a50b; FTIR spectra, DLS and z-potential analysis of the three series of samples; molybdate test calibration curve; PL-PLE spectra of FSNPs; SDS-PAGE of selected samples after soaking in BSA and human serum; semi-quantitative analysis of the serum protein adsorption on the SNP surface; cell viability tests on fibroblasts and RAW264.7 macrophages before and after BSA soaking at 24 h and 48 h; cell viability tests of bare and pegylated FSNPs on RAW 264.7 macrophages; raw flow cytometry data for the macrophages uptake of FSNPs]. (DOCX 4.70 mb)

References

  1. Alexander GB, Heston WM, Iler RK (1954) The solubility of amorphous silica in water. J Phys Chem 58:453–455CrossRefGoogle Scholar
  2. ASTM International (1988) Standard Test Method for Silica in Water. ASTM International, West ConshohockenGoogle Scholar
  3. Braun K, Pochert A, Beck M, Fiedler R, Gruber J, Lindén M (2016) Dissolution kinetics of mesoporous silica nanoparticles in different simulated body fluids. J Sol-Gel Sci Technol 79:319–327CrossRefGoogle Scholar
  4. Del Pino P, Pelaz B, Zhang Q, Maffre P, Nienhausand GU, Parak WJ (2014) Protein corona formation around nanoparticles-from the past to the future. Mater Horiz 1:301–313CrossRefGoogle Scholar
  5. Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of of medical nanoparticles. Int J Nanomedicine 7:5577–5591CrossRefGoogle Scholar
  6. Guo Z, Meng S, Zhong W, Du Q, Chou LL (2009) Self-assembly of silanated poly(ethylene glycol) on silicon and glass surfaces for improved haemocompatibility. Appl Surf Sci 255(15):6771–6780CrossRefGoogle Scholar
  7. Graf C, Gao Q, Schütz I, Noufele CN, Ruan W, Posselt U, Korotianskiy E, Nordmeyer D, Rancan F, Hadam S, Vogt A, Lademannv J, Haucke V, Rühl E (2012) Surface functionalization of silica nanoparticles supports colloidal stability in physiological media and facilitates internalization in cells. Langmuir 28(20):7598–7613CrossRefGoogle Scholar
  8. Harper GR, Davies MC, Davis SS, Tadros TF, Taylor DC, Irving MP, Waters JA (1991) Steric stabilization of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. Biomaterials 12(7):695–700CrossRefGoogle Scholar
  9. Jo S, Park K (2000) Surface modification using silanated poly(ethylene glycol)s. Biomaterials 21:605–616CrossRefGoogle Scholar
  10. Kopelman R, Xu H, Yan F, Monson EE, Tang W, Schneider R, Philbert M (2002) Preparation and characterization of poly(ethylene glycol)-coated Stöber silica nanoparticles for biomedical applications. SPIE (International Society of Photonic Engineering) Proc 4626:383–393Google Scholar
  11. Lee JA, Kim MK, Paek HJ, Kim YR, Kim MK, Lee JK, Jeong J, Choi SJ (2014) Tissue distribution and excretion kinetics of orally administrated silica nanoparticles in rats. Int J Nanomedicine 9:251–260Google Scholar
  12. Lenher V, Merrill HB (1917) The solubility of silica. J Am Chem Soc 39(12):2630–2638CrossRefGoogle Scholar
  13. Liu D, Lin B, Shao W, Zhu Z, Ji T, Yang C (2014) In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier. ACS Appl Mater Inter 6(3):2131–2136CrossRefGoogle Scholar
  14. Laysan Bio Inc. Material safety data sheet. (2013)Google Scholar
  15. Okner R, Domb AJ, Mandler D (2009) Electrochemically deposited poly(ethylene glycol)-based sol-gel thin films on stainless steel stent. New J Chem 33:1596–1604CrossRefGoogle Scholar
  16. Owens DE 3rd, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1):93–102CrossRefGoogle Scholar
  17. Phillips E, Penate-Medina O, Zanzonico PB, Carvajal RD, Mohan P, Ye Y, Humm J, Gonen M, Kalaigian H, Schoder H, Strauss HW, Larson SM, Wiesner U and Bradbury S, (2014) Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe. Sci Transl Med 6(260):260ra149Google Scholar
  18. Poteser M, Wakabayashi I (2004) Serum albumin induces iNOS expression and NO production in RAW 264.7 macrophages. Brit J Pharmaco 143(1):143–151CrossRefGoogle Scholar
  19. Rahman M, Laurent S, Tawil N, Yahia L, Mahmoudi M (2013) Protein-nanoparticle interactions: the bio-nano interface. Springer Series in Biophysics 15:21–44CrossRefGoogle Scholar
  20. Rimer JD, Trofymluk O, Navrotsky A, Vlachos DG (2007) Kinetic and thermodynamic studies of silica nanoparticle dissolution. Cem Mater 19(17):4189–4197Google Scholar
  21. Romberg B, Henninkand WE, Storm G (2008) Sheddable coatings for long circulating nanoparticles. Pharm Res 25(1):55–71CrossRefGoogle Scholar
  22. Sadzuka Y, Nakade A, Hirama R, Miyagishima A, Nozawa Y, Hirota S, Sonobe T (2008) Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int J Pharm 238(1–2):1711–1180Google Scholar
  23. Sahneh FD, Scoglio C, Riviere J (2013) Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations. PLoS One 8(5):e64690CrossRefGoogle Scholar
  24. Selvestrel F, Moret F, Segat D, Woodhams JH, Fracasso G, Rio Echevarria IM, Baù L, Rastrelli F, Compagnin C, Reddi E, Fedeli C, Papini E, Tavano R, Mackenzie A, Bovis M, Yaghini E, MacRobert AJ, Zanini S, Boscaini A, Colombatti M, Mancin F (2013) Targeted delivery of photosensitizers: efficacy and selectivity issues revealed by multifunctional ORMOSIL nanovectors in cellular systems. Nanoscale 5(13):6106-6116Google Scholar
  25. Stöber W, Fink A and Bohn E, (1968) Controlled growth of monodisperse silica sphere in the micron size range. Journal of Colloid and Interface Science26:62–69Google Scholar
  26. Tang L, Cheng J (2013) Nonporous silica nanoparticles for nanomedicine application. Nano Today 8(3):290–312CrossRefGoogle Scholar
  27. Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, Landfester K, Schild H, Maskos M, Knauer SK, Stauber RH (2013) Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8(10):772–781CrossRefGoogle Scholar
  28. Veronese FM, Pasut G (2005) PEGylation, successful approach to drug delivery. Drug Discov Today 10(21):1451–1458CrossRefGoogle Scholar
  29. Xie G, Sun J, Zhong G (2012) Tissular localization and excretion of intravenously administered silica nanoparticles of different sizes. J Nanopart Res 14:671–679CrossRefGoogle Scholar
  30. Xu H, Yan F, Monson EE, Kopelman R (2003) Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications. J Biomed Mater Res 66:870–879CrossRefGoogle Scholar
  31. Zhu XY, Jun Y, Staarup DR, Major RC, Danielson S, Boiadjev SV, Gladfelter WL, Bunker BC, Guo A (2001) Grafting of high-density poly(ethylene glycol) monolayers on Si(111). Langmuir 17(25):7798–7803CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2017

Authors and Affiliations

  • Giulia Glorani
    • 1
  • Riccardo Marin
    • 1
  • Patrizia Canton
    • 1
  • Marcella Pinto
    • 2
  • Giamaica Conti
    • 3
  • Giulio Fracasso
    • 2
  • Pietro Riello
    • 1
  1. 1.Dipartimento di Scienze Molecolari e NanosistemiUniversità Ca Foscari di VeneziaVenezia MestreItaly
  2. 2.Dipartimento di Medicina, Sezione di ImmunologiaUniversità degli Studi di VeronaVeronaItaly
  3. 3.Dipartimento di Scienze Neurologiche e del MovimentoUniversità degli Studi di VeronaVeronaItaly

Personalised recommendations